Trankimazin is a prominent European brand name (primarily used in Spain) for alprazolam, a highly potent, short-acting medication belonging to the benzodiazepine class. The 2 mg formulation represents a very high single-dose strength of this medication, often manufactured as a distinctive multi-scored "bar" or prolonged-release tablet designed to ease severe symptoms Because of its high potency and rapid onset, alprazolam carries a severe risk of physical dependence, tolerance, addiction, and acute withdrawal. For this reason, it is classified globally as a strictly controlled psychotropic substance Primary Medical Uses
Trankimazin is indicated strictly for short-term management under a physician's direct supervision for:
• Severe Anxiety Disorders: Short-term stabilization of disabling, acute generalized anxiety.
• Panic Disorder: Treatment of sudden, unexpected panic attacks, with or without agoraphobia.
• Anxiety Associated with Depression: Managing profound temporary distress How It Works
Alprazolam acts directly on the central nervous system by binding to GABA-A receptors in the brain. It dramatically enhances the effects of Gamma-Aminobutyric Acid (GABA), which is the primary inhibitory neurotransmitter in the brain. By dampening hyper-excited neuronal pathways, it quickly produces a powerful sedating, muscle-relaxant, and anxiolytic (anti-anxiety) effect.